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ABSTRACT
The Muscleblind (MBL) protein family is a deeply
conserved family of RNA binding proteins that regu-
late alternative splicing, alternative polyadenylation,
RNA stability and RNA localization. Their inactiva-
tion due to sequestration by expanded CUG repeats
causes symptoms in the neuromuscular disease my-
otonic dystrophy. MBL zinc fingers are the most
highly conserved portion of these proteins, and di-
rectly interact with RNA. We identified putative MBL
homologs in Ciona intestinalis and Trichoplax ad-
haerens, and investigated their ability, as well as that
of MBL homologs from human/mouse, fly and worm,
to regulate alternative splicing. We found that all ho-
mologs can regulate alternative splicing in mouse
cells, with some regulating over 100 events. The cis-
elements through which each homolog exerts its
splicing activities are likely to be highly similar to
mammalian Muscleblind-like proteins (MBNLs), as
suggested by motif analyses and the ability of ex-
panded CUG repeats to inactivate homolog-mediated
splicing. While regulation of specific target exons by
MBL/MBNL has not been broadly conserved across
these species, genes enriched for MBL/MBNL bind-
ing sites in their introns may play roles in cell ad-
hesion, ion transport and axon guidance, among
other biological pathways, suggesting a specific,
conserved role for these proteins across a broad
range of metazoan species.
INTRODUCTION
Splicing is a co- or post-transcriptional process in which
the spliceosome catalyzes excision of introns, or non-coding
regions, from a precursor RNA transcript while concomi-
tantly joining exons, or coding regions. This structure of ex-
ons and introns enables the generation of multiple mRNA
isoforms from a single gene through the exclusion and in-
clusion of exons and introns, leading to multiple protein
isoforms. Alternative splicing is a process that contributes
to the vast diversity observed in fungi, plant and animal
proteomes.Trans-acting protein factors can function as reg-
ulators of alternative splicing by interacting with specific
sequences, or RNA secondary structures, termed splicing
regulatory elements, within the RNA transcript to regulate
spliceosome recruitment to or interaction with splice sites.
These regulators can act in a spatio-temporal and develop-
mentally dependent manner to enhance or repress inclusion
of alternative exons (1,2).
Muscleblind (MBL) is a conserved family of RNA-
interacting proteins that regulate many aspects of RNA
metabolism, including tissue- and development-specific ac-
tivation or repression of alternative splicing (3). Plants,
fungi and bacteria lack any protein that resembles MBL, so
it appears that this family is exclusive to metazoans, evolv-
ing approximately 800 million years ago. Typically, inverte-
brates encode a single MBL gene, whereas vertebrates en-
code multiple MBL genes; humans and other mammals
have three muscleblind-like (MBNL1-3) genes. For simplic-
ity we will refer to all MBL/MBNL genes as muscleblind
and use this term or MBL when discussing this family of
genes/proteins. MBNL1 and MBNL2 are ubiquitously ex-
pressed in adult tissue, however, MBNL1 is more highly
expressed in muscle, and MBNL2 in brain (4). MBNL3
is developmentally regulated and is primarily expressed in
placental tissue and in muscle satellite cells, playing roles
in muscle regeneration and differentiation (5). The three
human/mouse MBNL paralogs undergo alternative splic-
ing, which affect localization and activity of the proteins.
Human MBNL1 contains 10 exons that can give rise to at
least 10 different splice isoforms (6,7). In particular, we fo-
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cus on the 41 kDa isoform ofMBNL1, which contain exons
1–4, 6–8 and 10.MBNL1 and 2 play a prominent role in the
RNA repeat-expansion disease myotonic dystrophy (DM).
In this disease, the sequestration of Muscleblind proteins to
expanded CUG repeats leads to mis-splicing of several mR-
NAs, causing several DM symptoms (8).MammalianMBL
is also involved in other RNA metabolic processes such as
regulation of gene expression (9,10), mRNA stability (11),
alternative 3′ end processing (12), localization (13,14) and
microRNA processing (15).
RNA binding by MBL proteins occurs through highly
conserved tandem CCCH-type zinc finger (ZnF) domains
(16). Many studies have strived to identify RNA motifs
recognized by MBNL1 and the mechanism by which it
binds to transcripts and regulates splicing. Fly (Drosophila
melanogaster) MBL and human MBNL1 tend to bind
YGCY (Y = C or U) containing RNA motifs (17,18).
CLIP-seq and RNA Bind-n-Seq experiments have identi-
fied slightly more specific and sub-optimal motifs, includ-
ing the 4mers GCUU and UGCU, with MBNL1 binding
specificity characterized as YGCY + GCUU (14,19).
We analyzed sequence conservation and explored the
splicing regulatory capacity of MBL proteins from Ciona
intestinalis (CiMBL), Trichoplax adhaerens (TaMBL) and
Caenorhabditis elegans (CeMBL), alongside human/mouse
MBNL1 andDrosophilaMBL. Using validated splicing re-
porter mini-genes in HeLa cells over-expressing MBL pro-
tein, we found that these homologs can regulate splicing of
specific, exogenous pre-mRNAs. RNAseq experiments ac-
cessing global splicing regulation in mouse embryonic fi-
broblasts (MEFs) stably expressing MBL proteins showed
that the homologs also regulate many endogenous targets.
MBL proteins from human, Ciona, fly, worm and Tri-
choplax are present in the nucleus and cytoplasm. Cyto-
plasmic localization suggests extra-nuclear activity, which
would further extend the functional conservation of non-
human MBLs beyond that of splicing regulation. Studying
distant MBL proteins may provide insight into ancestral or
novel functions that have been conserved from Trichoplax
to human MBNL proteins.
MATERIALS AND METHODS
Cloning, cell lines and splicing reporters
N-terminal HA-tagged DNA constructs encoding
HsMBNL1, Drosophila melanogaster (DmMBL), CeMBL,
CiMBL and TaMBL were cloned into the pCI plasmid
(Promega) using standard cloning procedures. HA-tagged
HsMBNL1 in pcDNA3 was previously cloned from
MBNL1-eGFP (17) obtained from the laboratory of
Maury Swanson. HA-DmMBL was cut directly out of a
previously cloned construct of HA-DmMBL in pcDNA3
using Kpn1 and Xba1 and inserted into pCI. CeMBL
DNA with N-terminal Bam H1 and C-terminal NotI
restriction enzyme cut sites was synthesized by GenScript
and received in pUC57 cloning vector. KpnI and XbaI
restriction enzymes were used to insert Ha-CeMBL into
pCI. CiMBL DNA with N-terminal HA-tag and EcoRI
cut site and C-terminal Sal1 restriction enzyme cut sites
was synthesized by GenScript and received in a pUC57
cloning vector. HA-CiMBL was inserted into pCI using
EcoRI and SalI. TaMBL cDNA was generously provided
by Dave Anderson (Thornton Lab, University of Oregon,
USA). Ha-TaMBL was inserted into pCI using KpnI and
XbaI restriction enzymes.
N-terminal GFP-tagged constructs encoding
HsMBNL1, DmMBL, CeMBL, CiMBL and TaMBL
were cloned into pAC156, a vector containing PiggyBac
Transposon (20) sequences flanking an EF1-driven
puromycin cassette, as well as an EF1 promoter present
to drive expression of the GFP-tagged construct (gifted by
Albert Cheng). The In-fusion cloning system (Clontech)
was used according to the manufacturers instructions,
to clone the GFP-tagged constructs into pAC156. At
60% confluency, MEFs deficient in MBNL1/2, gifted by
Maurice Swanson, were transfected with 2 g plasmid
encoding GFP-Muscleblind using TransIT (Mirus) and
500 ng of PiggyBac transposon to stably introduce GFP-
Musclebind into the cells. After 24 h the cells were subjected
to puromycin selection (2 g/ml), allowed to recover for
several days and sorted for similar GFP-expression. The
cell lines were maintained in puromycin.
Reporter constructs used for the splicing assay were
previously cloned; TNNT2 was gifted from laboratory of
Thomas Cooper (21). ATP2A1 (22), MBNL1 (23) (Figure
1C) and INSR were from Nicholas Webster (24) and Nfix,
and Vldlr were fromManuel Ares, Jr. (10). TheMBNL1 re-
porter used in Supplementary Figure S4A was previously
created by us and described (25).
Cell culture
HeLa cells were maintained as a cultured monolayer in
Dulbecco’s modified Eagle’s medium (DMEM) +GLUTA-
MAX media supplemented with 10% fetal bovine serum
(FBS) and 10% antibiotic-antimycotic (Gibco, Invitrogen).
The cells were kept at a constant temperature of 37◦C
in a humidified incubator (5% CO2). MEF cells (gifted
by Maury Swanson) were maintained in DMEM supple-
mented with 20% FBS, 5% penicillin/streptomycin and 2
g/ml puromycin at 37◦C and 5% CO2.
Western blots
HeLa cells were lysed in RIPA lysis buffer (100 mM Tris
pH 7.4, 300 mM NaCl, 10% NP40, 10% Na-deoxycholate,
protease inhibitor, 200 mM PMSF, 10% SDS). Protein con-
centration was quantified using BCA reagent (Thermo Sci-
entific) following manufactures instruction. Total protein
lysates (5 g) were loaded on 12% SDS-Page denaturing
gel, electrophoresed for 40 min and transferred via a fast
partial wet transfer (200 mA and 100 V for 2 h) to a 0.45
mpore size nitrocellulosemembrane (GEWater&Process
Technologies). Following protein transfer, a Ponceau stain
(Sigma-Aldrich) was performed in order to ensure proper
transfer. TBSTwas used to wash the nitrocellulose. The blot
was blocked for 4 min in 4% milk in TBST prior to admin-
istration of the primary antibody. All blots were exposed to
primary antibody at a dilution of 1:1000 (antibody: 4%milk
in TBST) overnight at 4◦C and exposed to secondary anti-
body at a dilution of 1:2000 for 2 h at room temperature.
HA-probe (F7) mouse polyclonal IgG antibody and actin
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Figure 1. Distant Muscleblind (MBL) homologs regulate splicing in a transcript-dependent manner. (A) BLASTX searches, using human MBNL1
(HsMBNL1, identical tomouseMBNL1) as query, identified homologs inCiona intestinalis (CiMBL),Drosophila melanogaster (DmMBL),Caenorhabditis
elegans (CeMBL) and Trichoplax adhaerens (TaMBL). DmMBL is overall most similar to HsMBNL1 based on local alignment calculations. Zinc-Finger
(ZnF) RNA-binding domains are highly conserved. (B) Transfected HeLa cells express similar levels of HA-tagged Muscleblind proteins. (C) MBL ho-
mologs can activate or repress splicing of aMBNL1 exon 5minigene or (D)ATP2A1 exon 22minigene with varying activity (shown asmean percent spliced
in, or ). (E) Non-HsMBNL1 splicing activity varies depending on the minigene substrate; darker purple represents higher activity. Splicing activity is
displayed relative to HsMBNL1 splicing, where activity is represented as the percentage change in  in the presence of the homolog relative to mock,
divided by the percentage change in  in the presence of HsMBNL1 relative to mock (n ≥ 4).
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(I-19) rabbit polyclonal IgG (Santa Cruz Biotech) primary
antibodies were used.
MEFs grown to 80% confluence were scraped, re-
suspended into lysis buffer (20 mM Tris pH 8.0, 200 mM
NaCl, 2 mM MgCl2, 10% Glycerol, 1% NP40, EDTA-
free protease inhibitor tablet (Roche, Mini, EASYpack),
PhosSTOP phosphatase inhibitor cocktail tablet (Roche)),
incubated 20 min on ice, spun down at 4◦C for 10 min at
14 000 rpm. Supernatant was collected and concentration
was accessed via Bradford assay. A total of 25 g protein
lysate was loaded on a NuPAGE Bis-Tris Gel (Novex, Life
Technologies), electrophoresed and transferred to iBlot2
stacks (ThermoFisher). A ponceau stain confirmed trans-
fer and equal protein loading/sample. Blots were blocked
in 5% milk in TBST, exposed over night to primary anti-
bodies (Ms MB1a from the CIND Monoclonal Antibody
Resource 1:2000; Rb Anti-GFP (Abcam ab290, GR19763),
1:5000; Rb Anti-actin (Cell Signaling, #4967S), 1:5000),
washed thoroughly and exposed to appropriate secondary
antibodies for 2 h at room temperature.
Reporter splicing assay
HeLa cells were plated in 6-well plates at a density of
1.6–1.8 × 106 cells/well. At 80–90% confluency, cells were
co-transfected with 500 ng/well of splicing reporter and
MBNL/MBL-encoding or GFP-encoding (mock) plasmid
using Lipofectamine 2000 reagent (Invitrogen) in OPTI-
MEM reduced serum medium (Gibco, Invitrogen). After 4
h, media was replaced with DMEM+GLUTAMAX. After
18–24 h, cells were harvested with with TripleE (Gibco, In-
vitorgen). Experimental procedures follow those previously
described (22). RNA was isolated via RNAEasy Kit (Qia-
gen) according to the manufacturer’s instructions and 500
ng of RNA was DNAse-treated (RQ1 DNAse, New Eng-
land Biolabs). DNAsed RNA [2 l (100 ng)] was reverse
transcribed (RT) with SuperScript II reverse transcriptase
(Invitrogen), according to Invitrogen’s protocol, except that
half the amount of recommended amount of SuperScript
II was used. cDNA was PCR amplified for 20–26 cycles us-
ing reporter-gene specific primers. PCRproducts (5l) were
dyed (Sybr Green DNA loading dye, Invitrogen), resolved
on a 6% native acrylamide gel (19:1) and quantified using
AlphaImager and associated software (Alpha Innotech).
CTG repeat-containing plasmids (DT480 andDT960) were
gifted from Tom Cooper and co-transfected with reporter
genes.
Percent exon inclusion was calculated by dividing the
background-corrected amount of inclusion splice prod-
uct by the total amount of splice product (background-
corrected inclusion splice product + background-corrected
exclusion product). Splicing activity relative to human
MBNL1 was calculated in the following way: (non-HsMbl
– mock inclusion) / (HsMBNL – mock inclusion).
Immunofluorescence
MEF cell lines expressing GFP-Muscleblind were plated
(∼1.25 × 105 cells/well) on collage-coated coverslips (100
g/l), incubated overnight (∼18 h) and fixed using 4%
paraformaldehyde, 15 min at room temperature. Cells were
washed in phosphate buffered saline (PBS), permeabilized
in 0.2% Triton-X/PBS at room temperature, 3 min, blocked
in 10% bovine serum albumin (BSA)/PBS at 37◦ for 30 min
and exposed to primary antibody, 1:1000 chicken IgY -
GFP (Aves) diluted in PBS + 1% BSA, at 4◦ overnight. Af-
ter washing in PBS, the secondary antibody, -chicken 488
at 1:400 and 594 phalloidin (LifeTechnologies) at 1:400 di-
luted in PBS + 1% BSA, were incubated on the coverslips
at 37◦C for 1 h. Coverslips were washed in PBS and subject
to Hoechst stain at room temperature for 10 min before fi-
nal PBS washes and mounting onto microscopic slides. All
cells in Figure 3 and Supplementary Figure S2A were im-
aged on an Applied Precision DeltaVision Microscope at
60X magnification, optical sections were deconvoluted us-
ing the associated software, and processed using ImageJ.
Adjusted intensity projections were generated from the av-
erage of three z stacks, centered around the nucleus. HeLa
cells, transfected withHA-Muscleblind, were processed and
imaged similarly except that they were fixed after a 2 h in-
cubation; HA-probe (F7) mouse polyclonal IgG primary
antibody (1:1000) was used, and images represent a sin-
gle z stack. Cells in Supplementary Figures S2B and S4B
were imaged on a Zeiss LSM880 at 63x magnification using
confocal microscopy. Maximum Z-projections are shown.
FISH against CUG repeats was performed as previously de-
scribed (26), using a (CAG)10 probe conjugated to CalFluor
610 (Biosearch Technologies).
RNAseq
Total RNAwas isolated fromGFP-Muscleblind expressing
MEF cells usingDirect-zolRNAcolumns (ZymoResearch)
according to manufacturer’s instructions. cDNA libraries
were generated starting with 1 g RNA. Briefly, RNA was
fragmented, depleted of ribosomal RNA using Ribo-Zero-
Gold kit (Epicentre), and reverse transcribed followed by
end-repair, adenylation and adapter ligation. Unique bar-
codes were used for each library to allow for multiplex-
ing all samples in a single lane (80 + 80 bases, paired-end,
NextSeq). STAR (27) was used to align reads to the mouse
mm9 genome, and MISO (28) was used to quantify splic-
ing. All RNAseq data have been deposited in GEO under
accession number GSE79095.
Motif analysis
The frequency of GCTT, CGCT, TGCT or GCGC (MBNL
binding) motifs was compared to the frequency of con-
trol 4-mers with the same A+T and CpG content in the
skipped exon and 250 bp of introns downstream of the up-
stream constitutive exon, upstream of the skipped exon,
downstream of the skipped exon and upstream of the down-
stream constitutive exon. Skipped exons were grouped into
those activated by MBNL homologs (BF > 5,  > 0.1,
Z > 1.5 in WT versus DKO), those repressed by MBNL
homologs (BF > 5,  < −0.1, Z > 1.5 in WT versus
DKO), or those not affected by MBNL homologs. The
log2(enrichment of MBNL binding motifs relative to con-
trols in activated exons/enrichment of MBNL binding mo-
tifs relative to controls in unaffected exons) was plotted in
heatmap form. A similar metric was plotted for repressed
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exons. Genome sequence for mouse mm9 was downloaded
from UCSC genome browser.
Gene ontology analysis
For each species, multiple alignments were used to ana-
lyze the branch length across which MBL/MBNL bind-
ing motifs are conserved in the 150 nucleotides flank-
ing all internal exons. Multiple alignments and branch
lengths for human, mouse, fly and worm were down-
loaded from UCSC genome browser; multiple alignments
for Ciona were downloaded from the Joint Genome Insti-
tute. For human, Refseq gene annotations were used; mul-
tiple alignments included hg38, panTro4, rheMac3, mm10,
rn5, canFam3 and monDom5. For mouse, Refseq gene an-
notations were used; multiple alignments included mm9,
rn4, canFam2, bosTau3, monDom4, galGal3, xenTro2,
danRer5 and tetNig1. For fly, Refseq gene annotations
were used; multiple alignments included dm6, droSim1,
droYak3, droAna3, droPse3, droVir3, droMoj3, anoGam1
and apiMel4. For worm, Wormbase gene annotations were
used; multiple alignments included ce10, cb4, caeRem4,
caeSp111, caePb3, caeJap4 and caeAng1. For Ciona, En-
sembl gene annotations were used; a pairwise alignment of
Ciona intestinalis and Ciona savignyi was downloaded from
JGI (http://pipeline.lbl.gov/data/Cioin2 cioSav2/). For each
intronic region, the branch length across which 4-mer mo-
tifs were conserved was recorded. The mean branch length
of GCTT, CGCT, TGCT or GCGC (MBL/MBNL bind-
ing) motifs, less the mean branch length of control motifs
with the same A+T and CpG content, yielded intron. The
largest intron for all introns in each gene was kept as gene.
Then, for each Gene Ontology category, the distribution of
gene for genes within the category was compared to the dis-
tribution of gene for all genes outside the category, using
a ranksum test. P-values were Benjamini–Hochberg cor-
rected, andP-values were converted to 1 for those categories
with lower mean gene as compared to controls.
RESULTS
Muscleblind homologs regulate splicing of mammalian mini-
gene reporters
To gain insight into conservation of function of the MBL
family of RNA binding proteins, we studied MBL proteins
from five diverse organisms including Homo sapiens/mus
musculus (protein coding sequences are identical); Ciona
intestinalis, a primitive chordate; Drosophila melanogaster
and Caenorhabditis elegans, two commonly used model
organisms; and Trichoplax adhaerens, a basal metazoan.
Using the human/mouse 41 kD isoform of MBNL1 se-
quence as a query, we performed BLAST searches to iden-
tify homologs in these organisms. The 41 kD isoform of
MBNL1 contains the linker region between both pairs
of zinc fingers (exon 3), lacks exon 5, which can control
nuclear/cytoplasmic localization, and lacks exon 7, which
has been proposed to contribute to MBNL1 dimeriza-
tion (6). This isoform has been extensively studied and
exhibits both nuclear and cytoplasmic distribution (29).
Zinc-finger X1 in Ciona, Muscleblind D in Drosophila,
Muscleblind-1a in Caenorhabditis and a hypothetical pro-
tein in Trichoplax were identified as the highest scor-
ing homologs. For clarity, we refer to these proteins as
HsMBNL1, CiMBL, DmMBL, CeMBL and TaMBL for
human, Ciona, Drosophila, Caenorhabditis and Trichoplax
Muscleblind proteins, respectively. To quantify the extent
of overall protein homology, Smith–Waterman alignments
comparingHsMBNL1 to each homolog, and the associated
similarity scores, which reflect aligned residues with similar
properties, were calculated (Figure 1A). DmMBL showed
the highest overall similarity score of 62.8%, followed by
TaMBL, CiMBL and CeMBL.
The Muscleblind family contains CCCH-type ZnF
RNA-binding domains, normally occurring as a tandem
pair. Our multi-species alignment shows that the ZnF do-
mains are highly similar and are the most conserved re-
gions of these proteins (Figure 1A, far right), despite the
fact that the number of ZnFs, internal spacing between the
conserved cysteine and histidine residues, and spacing be-
tween tandem ZnF domains vary among each homolog.
Some regions outside of the ZnF domains are also con-
served and have been previously shown to be important for
MBL function. The motifs RD/KWL, or LEV box, and
KxQL/NGR, which closely flank the first ZnF pair, are in-
volved in nuclear localization for humanMBNL1 (3,7), and
may be present in DmMBL, CeMBL and TaMBL (Supple-
mentary Figure S1). The linker region between tandemZnF
pairs exhibit the next highest density of conserved residues
outside of the ZnFs. Mutation and truncation analysis in
this linker region has demonstrated its importance for hu-
manMBNL splicing activity (6,30). Finally, numerous pro-
line residues are conserved, some of which lie in the linker
region and have been previously shown to interact with
Src family kinases and alter their activity (31). The overall
similarity between the MBL proteins in our study, particu-
larly within the RNA-binding domains, suggests conserved
RNA binding and provided the rationale for investigation
of conserved splicing regulation by these homologous pro-
teins.
To initially explore splicing of the MBL homologs, we
conducted cell-based splicing assays using mini-gene re-
porters. Transfection of HA-tagged expression vectors en-
coding each homolog yielded similar, high expression lev-
els in HeLa cells, as assessed by Western blot (Figure 1B).
The homologs were also observed in both nuclear and cy-
toplasmic compartments of transfected HeLa cells (Sup-
plementary Figure S2A). Splicing reporter mini-genes, in-
cluding human cardiac troponin T type 2 (TNNT2) exon 5
(17), mouse nuclear factor I/X (Nfix) exon 8 (10), human
MBNL1 exon 5 (23), human sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase 1 exon 22 (ATP2A1) (22), mouse
very-low-density lipoprotein receptor (Vldlr) exon 1610, and
human insulin receptor exon 11 (INSR) (32) were co-
transfected with MBL/MBNL homolog or GFP (control).
Inclusion levels of each alternative exon was quantitated
by RT-PCR, and expressed as percent spliced in () and
also splicing activity as a percentage of activity relative to
HsMBNL1. Across all mini-gene reporters tested, we ob-
served the same direction of splicing regulation (either ac-
tivation or repression) for all homologs, with varying de-
grees of regulation relative to HsMBNL1. For example, ex-
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pression of HsMBNL1 represses inclusion ofMBNL1 exon
5 from 67% to 19%; all MBL homologs exhibited simi-
lar repressive activity, but at varying degrees, with CeMBL
exhibiting the weakest activity ( = 44%) (Figure 1C).
Similarly, all MBL homologs could enhance inclusion of
ATP2A1 exon 22, raising  from 15% to between 55–79%
(Figure 1D).
Homologs that most strongly repressed MBNL1 exon
5 were not necessarily those that most strongly enhanced
ATP2A1 exon 22. Assessment of splicing activity using ad-
ditional reporters revealed that potency of MBL/MBNL
splicing activity depends on the specific transcript (Figure
1E, Supplementary Figure S3). These differences in activity
may be due to differences in cis-element architecture of the
reporters, and also differences in the MBL/MBNL activity
due to sequence variation between homologs. Among the
reporters tested, DmMBL exhibited the most potent splic-
ing activity relative to HsMBNL1, CeMBL was the poor-
est regulator for two of the reporters and TaMBL exhib-
ited 60–80% activity, regardless of reporter. These results
are consistent with previous data showing that HsMBNL1
and DmMBL act as both activators and repressors of alter-
native splicing; here, we observe that CeMBL, CiMBL and
TaMBL also exhibit these activities.
MBNL1/2 null cells reconstituted with MBL homologs were
generated to test global splicing regulation
To assess the ability of the MBL homologs to regulate
endogenous transcripts across the transcriptome, indepen-
dent of potential over-expression artifacts, we established
stable cell lines expressing each homolog. First, to iden-
tify endogenous targets of mouse MBNL proteins, we per-
formed RNAseq on 3 independent wild type MEF clones
and 3 independentMBNL1/2 knockout MEF clones (dou-
ble knockout, or DKO, Figure 2A). We then selected one
of the DKO clones and stably integrated an expression
cassette containing each N-terminal GFP-tagged homolog,
driven by the EF1 promoter, along with a puromycin se-
lection cassette. Following puromycin selection, we used
fluorescent-activated cell sorting to select cells that express
similar levels of GFP-tagged MBL homolog. RNAseq li-
braries were generated from the five cell lines and an addi-
tional line expressing GFP alone (Figure 2B). Expression
levels of GFP-tagged homologs were comparable across all
lines, as assessed by Western blot (Figure 2B).
We determined the subcellular localization of each ho-
molog in our cell lines using immunofluorescence against
GFP (Figure 2C). All homologs showed some nuclear and
cytoplasmic distribution, consistent with previous observa-
tions of the 41 kD isoform of HsMBNL1, of DmMBL, and
CeMBL (6,33,34). The control, GFP-expressing cell line
also showed localization to both nuclear and cytoplasmic
compartments (Supplementary Figure S2B). Differences in
nuclear-cytoplasmic localization may be due to differences
in protein sequence among the homologs, cell type, cell state
and/or extracellular signals, but presence in the nucleus is
consistent with a conserved function in regulation of splic-
ing.
Endogenous exons are regulated byMBL homologs in recon-
stituted DKO cells
RNAseq reads were mapped by STAR (27) to the genome
and splice junctions, yielding 76M, 51M, 65M, 51M, 38M
and 70M uniquely mapping reads from GFP, Hs, Ci, Dm,
Ce and Ta-reconstituted lines, respectively. Psi values were
quantitated using MISO (28) across all alternative splic-
ing events. Clear examples of MBNL-regulated events that
could also be regulated by each of the homologs were ob-
served. For example,Map4k4 exon 20 is included from 64–
73% in WT MEFs, but at 36–42% in DKO MEFs; ho-
molog expression was sufficient to enhance inclusion to
62–88%, depending on the homolog (Figure 3A). We fur-
ther analyzed alternative splicing events across the tran-
scriptome, focusing on events that were MBNL-dependent
(those that exhibit a monotonicity Z-score ≥ 1.5 between
WT and DKO MEFs, Supplementary Table S1) and could
be rescued by any given homolog (MISO Bayes Factor ≥
5 and | | ≥ 0.1, Supplementary Table S2). We identi-
fied 194, 158, 92, 112 and 91 exons significantly regulated
in Hs, Ci, Dm, Ce and Ta-MBL reconstituted cells, re-
spectively (Figure 3B, Supplementary Table S2). All major
classes of splicing event types were represented, including
skipped/cassette exons, retained introns, mutually exclusive
exons and alternative 5′ or 3′ splice sites. Both splicing acti-
vation and repression activities were observed for each ho-
molog, with a slight bias toward exon inclusion for Hs and
Ce (binomial P-values < 0.01) (Figure 3C).
Across the transcriptome, significantly regulated splic-
ing changes in cells lacking MBNL1/2 strongly correlated
with splicing changes in DKO cells re-constituted with
HsMBNL1 (R2 = 0.86, Figure 3D). Other homologs also
showed positive correlations, with R2 values ranging from
0.43 (Dm) to 0.71 (Ce). In general, the direction of splic-
ing regulation (activation or repression) byMBL homologs
was consistent with regulation by endogenous MBNLs; the
number of events regulated by one or more homologs is
shown in SupplementaryFigure S3B. To compare the extent
to which each homolog regulates splicing, we plotted the
magnitude of splicing regulation for each ortholog (| |)
relative to control (GFP-expressing) cells. HsMBNL1 and
TaMBL exhibited the most and least dramatic regulation,
respectively, as assessed by median | | relative to control
(GFP-expressing) cells (Figure 3E).
Splicing events that were significantly regulated by a
greater number of homologs tended to be regulated in a di-
rection consistent with that observed when comparing WT
to DKO MEFs (Figure 4A). In addition, the magnitude of
splicing regulation conferred by MBNL, as assessed when
comparing WT versus DKO MEFs, was larger for those
events regulated by a greater number of homologs relative to
those regulated by fewer homologs (Figure 4B, Supplemen-
tary Table S2). As has been previously observed, YGCY
motifs are enriched in the introns downstream of exons ac-
tivated by MBNL, and in the upstream introns and exons
repressed by MBNL, relative to control exons, as assessed
when comparingWT toDKOMEFs (Figure 4C). Themag-
nitude of this enrichment was slightly increased among ex-
ons regulated by more than two homologs (Figure 4C).
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Figure 2. RNAseq libraries were generated fromWT, MBNL1/2 knockout (DKO) and Muscleblind-reconstituted mouse embryonic fibroblasts (MEFs).
(A and B) MBNL1/2 double knockout MEFs (DKO) were reconstituted with GFP or GFP-tagged Muscleblind proteins from a single DKO clone, and
sorted to select for similar GFP expression. RNAseq libraries were prepared from three WT clones, three DKO clones and the sorted, reconstituted clones
(plates with red outlines). Each clone expresses similar levels of MBL/MBNL homolog, as assessed by Western blot. (C) Immunofluorescent staining of
each reconstituted line shows MBL proteins in both nucleus and cytoplasm. Anti-GFP (MBL/MBNL1), green; Hoechst (nuclear stain), blue; phalloidin
594 (F-actin), red; scale bar, 20 m.
MBNL homologs can rescue CUG repeat-dependent mis-
splicing, and colocalize with expanded CUG repeats
Given the ability of each homolog to regulate exons in a
manner similar to human/mouse MBNL, we tested their
abilities to rescue CUG repeat-mediated aberrant splic-
ing of MBNL1 exon 5, TNNT2 exon 5, Nfix exon 8 and
ATP2A1 exon 22 in the context of a minigene reporter. Co-
transfection of each homolog in HeLa cells could partially
rescue mis-splicing (Supplementary Figure S4A), suggest-
ing that each homolog may compete for binding to CUG
repeats to release endogenousMBNLs, through recognizing
a binding site similar to that recognized by human/mouse
MBNLs. In further support of this hypothesis, we also
tested the ability of each homolog to bind to expanded
CUG repeats. Transfection of a plasmid encoding 480 CTG
repeats into the reconstitutedMEFs yieldedGFP foci in the
nucleus of each cell line (Supplementary Figure S4B), al-
though flyMBL did not yield foci as strong as the other ho-
mologs. This fly isoform has been previously demonstrated
to bind CUG repeats more weakly than theMBNL binding
site found in intron 4 of cardiac troponin T (18).
Enrichment of MBNL binding motifs in introns of specific
Gene Ontology categories across evolution
To gain insight into properties of MBL/MBNL target ex-
ons throughout evolution, we analyzed exons in species with
reasonably comprehensive gene ontology annotations (Tri-
choplaxwas omitted from this analysis).We usedmotif con-
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Figure 3. Distant MBL homologs regulate splicing of many endogenous exons in a manner similar to humanMBNL1. (A) RNAseq read coverage across
Map4k4 exon 20 shows an example of alternative splicing regulation in WT, DKO andMBL-reconstituted MEFs. MISO values and 95% CIs are shown
at right. (B) All types of alternative splicing are regulated by MBL homologs. (C) Number of spliced exons activated (white bar) or repressed (black
bar) by MBL homologs. Hs and Ce show significantly more splicing activation than repression. (D) Reconstitution of MBL homologs rescues splicing in
MBNL1/2 DKOMEFs. Exons significantly regulated in WTMEFs: gray points; exons significantly regulated in reconstituted cell lines: red (Hs), orange
(Ci), yellow (Dm), green (Ce), blue (Ta) points. Black numbers in quadrants show the number of exons significantly regulated in reconstituted cells. Red
numbers show the number of exons significantly regulated by both HsMBNL1 and associated MBL homolog. (E) Boxplot of absolute splicing changes,
| |, for colored points in (D) shows that HsMBNL1 exhibits the strongest splicing regulation, whereas TaMBL exhibits the weakest.
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Figure 4. Splicing events regulated by multiple MBL/MBNL homologs are enriched for properties typical of MBL/MBNL targets. (A) The fraction of
events in which 1–5 orthologs regulate each splicing event (BF > 5, | | > 0.1) in the same direction as observed in WT versus DKO is shown in bars.
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events regulated between WT and DKO cells, those also regulated by 1–2 orthologs, and those regulated by 3 or more orthologs. (D) Enrichment of Gene
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blue shading in a heatmap. Only categories significantly enriched (P < 0.01, Benjamini–Hochberg corrected) in at least four organisms are shown.
servation to predict MBL/MBNL target exons, and asked
whether particular gene ontology categories were enriched
among putative MBL/MBNL target genes. We first com-
puted branch length conservation for topMBL/MBNL tar-
get 4-mers, as previously assessed by RNA BindNSeq (19),
within introns−150 to−1 upstream of each exon and +1 to
+150 downstreamof each exon. Branch length conservation
was assessed using multiple alignments of human introns
relative to 6 vertebrate species, mouse versus 8 vertebrates,
D. melanogaster versus 8 insects, C. elegans versus 5 worms
and C. intestinalis versus C. savignyi. We asked whether
the mean branch length of MBNL motifs was higher than
expected, relative to control motifs, in genes within each
gene ontology category. Interestingly, we found that gene
ontology categories containing the most highly conserved
MBL/MBNL motifs were similar across broad evolution-
ary time (Figure 4D). For example, ‘calcium ion binding’,
‘ATP binding’ and ‘actin filament binding’ were enriched
across at least 4 of the 5 analyses, as well as ‘membrane’, ‘ion
transport’ and ‘cell adhesion’. While specific target exons
of MBL/MBNL proteins have not necessarily been con-
served across such large evolutionary distances, a role for
MBL/MBNL in mediating the splicing of genes involved
in particular biological functions may be conserved across
millions of years of evolutionary time.
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DISCUSSION
DiverseMuscleblind homologs regulate alternative splicing of
mammalian transcripts
Splicing reporter assays in HeLa cells and RNAseq analy-
sis of endogenous transcripts in MEFs reconstituted with
MBL proteins from fly, worm, Ciona or Trichoplax showed
conserved alternative splicing regulation that positively cor-
related with splicing activity observed with the mammalian
MBNL proteins (Figures 1 and 3). These observations in-
dicate a strongly conserved role for Muscleblind proteins
as regulators of alternative splicing across all metazoans.
A multi-species alignment between the homologs revealed
that the CCCH-type ZnF–RNA binding regions are the
most conserved regions between species (Figure 1A and
Supplementary Figure S1). A lack of conservation existing
outside of the RNA binding domains suggests that these
proteins regulate splicing primarily via interactions between
ZnF domains and YGCY binding sites found in RNAs of
MBL/MBNL-regulated events.
Differences observed in splicing regulation by the ho-
mologs may be attributable to differences in the number of
ZnFs, differences in ZnF binding affinity or specificity, and
spacing between tandem ZnF domains. These ZnF prop-
erties have been previously shown to affect HsMBNL1–
RNA interaction and splicing regulation (35). While we did
not observe an obvious correlation between homolog ZnF
number and the extent of splicing regulation, it is plau-
sible that some substrates are more strongly regulated by
MBL homologs containing a greater number of ZnFs. The
Drosophila homolog we studied contains 2 ZnFs, but ho-
mologs with 4 ZnFs have also been described (36); it would
be interesting to compare their activities.
Context-dependent splicing activity of Muscleblind is con-
served across metazoans
Our results are consistent with previous studies that have
shown that other alternative splicing factors have main-
tained their RNA regulatory maps (binding motifs up-
stream of exons and within exons correlates with repression
and motifs present downstream of exons correlates with ac-
tivation). The best studied is Nova, whose RNA binding
protein domains are 94% identical across vertebrates (37).
Nova homologs from Sea anemone, fly and lancelet can reg-
ulate several splicing events across different species (38),
and Pasilla (Drosophila Nova homolog) globally regulates
splicing using an RNA regulatory map similar to mouse
(39). However, while Nova binding site clusters are mod-
erately conserved to chicken and zebrafish (37), few exons
have been discovered to be conserved between mammals
and fly (39). The 12 splicing events regulated by all MBL
homologs are notable for the large for these events (Fig-
ure 4B), which is twice the mean  for events regulated
by four or fewer homologs. A possible explanation for why
these events are regulated by all homologs is that these ex-
ons contain multiple and redundant MBL/MBNL binding
sites that facilitate robust binding and splicing regulation.
Enrichment of YGCY motifs downstream of activated ex-
ons and within repressed exons regulated by more than two
homologs is consistent with this model (Figure 4C).
Muscleblind homologs localize to the nucleus and cytoplasm
Nuclear localization of MBL/MBNL homologs is consis-
tent with a conserved nuclear function and splicing activ-
ity (Figure 2 and Supplementary Figure S2). Varying lev-
els of nuclear/cytoplasmic localization across the homologs
could partially or fully explain the differences in splicing
activity. For example, CeMBL is located primarily in the
nucleus (Figure 2) and exhibits the strongest correlation
(R2 = 0.71) to WT cells after HsMBNL1 (Figure 3). These
homologs may also exhibit other functions in the cyto-
plasm; the MBL family has been implicated in regulating
mRNA export/localization, mRNA decay and alternative
3′ end processing (11–14). It will be of interest to determine
whether extra-nuclear functions of MBL/MBNLs are also
conserved across evolutionary time.
Genes with conserved Muscleblind binding motifs may be in-
volved in similar biological pathways
We predicted splicing targets of MBL homologs in hu-
man, mouse, worm, fly and Ciona, by identifying genes
containing highly conserved MBL/MBNLmotifs. Surpris-
ingly, these analyses revealed that even though specific tar-
get exons may not be conserved throughout metazoan evo-
lution, MBL proteins are predicted to regulate the splicing
of genes involved in similar biological pathways, such as cell
adhesion, axon guidance and ion transport.While our path-
way analyses extended across human, mouse, fly, worm and
Ciona, we were not able to assess biological pathways inTri-
choplax that may be regulated by MBL/MBNLs, due to a
lack of robust annotations. Given that Trichoplax is a very
simple organism, with only six described cell types and no
evident sensory, muscle or nerve cells (40), the function of
TrichoplaxMBL in its native context may be interesting to
investigate, and potentially reveal some of the most ancient
functions of the MBL family.
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